Related Experiment Video
Updated: Aug 10, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Interferon-gamma ELISPOT assay for the quantitative measurement of antigen-specific murine CD8+ T-cells
1Point Therapeutics Inc., Boston, MA, USA.
Insights
This study details an interferon-gamma ELISPOT assay for quantifying antigen-specific CD8+ T-cells. This method enables sensitive detection of cellular immune responses, crucial for vaccine and immunotherapeutic development.
Area of Science:
- Immunology
- Cellular Biology
- Vaccinology
Background:
- Quantitative measurement of cellular immune responses is essential for screening new vaccines and immunotherapeutics.
- The enzyme-linked immunospot (ELISPOT) assay is a sensitive technique for detecting cytokine-producing cells at the single-cell level.
- ELISPOT assays are rapid, reproducible, and allow direct enumeration of low-frequency antigen-specific T-cells.
Purpose of the Study:
- To describe a detailed protocol for an interferon (IFN)-gamma ELISPOT method.
- To demonstrate the measurement of antigen-specific murine CD8+ T-cells using this technique.
- To highlight the utility of ELISPOT for monitoring CD8+ T-cell responses in various model systems.
Main Methods:
- Utilized spleen cells from peptide-primed mice as a source of CD8+ T-cells.
- Employed a ready-to-use IFN-gamma ELISPOT assay kit for assay facilitation.
- Detailed the step-by-step procedure for the IFN-gamma ELISPOT assay.
Main Results:
- Successfully demonstrated the utility of the IFN-gamma ELISPOT assay for enumerating antigen-specific CD8+ T-cells.
- The assay provides quantitative measurement of cellular immune responses at the single-cell level.
- The protocol is adaptable to other model systems for monitoring CD8+ T-cell responses.
Conclusions:
- The described IFN-gamma ELISPOT method is effective for quantifying antigen-specific murine CD8+ T-cells.
- This assay is a valuable tool for the effective screening of vaccines and immunotherapeutics.
- The protocol's adaptability makes it broadly applicable in immunological research.
Abstract:
Effective screening of new vaccines and immunotherapeutics requires assay methods that can provide quantitative measurement of cellular immune responses. The enzyme-linked immunospot (ELISPOT) is a sensitive technique for the detection of cytokine-producing cells at the single cell level. This assay is rapid and reproducible and permits the direct enumeration of low-frequency antigen-specific T-cells. This protocol describes in detail an interferon (IFN)-gamma ELISPOT method for measuring antigen-specific murine CD8+ T-cells. Spleen cells from specific cytotoxic T-lymphocyte (CTL) peptide-primed mice are used source of CD8+ T-cells to demonstrate the utility of this technique. The assay procedure is facilitated by the use of a ready-to-use IFN-gamma ELISPOT assay kit and it can be adapted to other model systems in which CD8+ T-cell responses are monitored.
More Related Videos
08:04Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 10, 2014
08:13Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination
Published on: January 20, 2019